NEW YORK (AP) -- Andrew Witty, who took over as GlaxoSmithKline PLC's chief executive in May 2008, has been remaking the company from a pure pharmaceutical business to a diverse healthcare conglomerate, a strategy most rivals now are pursuing....
pharmaceutical businessGlaxo CEO: Time to diversify, help poor countriesHeadlines from the Associated Press Tue, 02/02/2010 - 15:56
|
